When you’re referring a patient who is indicated for an ICD, determine if he or she is a good candidate for S-ICD: the first and only FDA-approved subcutaneous implantable defibrillator that leaves the vasculature untouched and avoids the risks associated with transvenous leads.
A new generation of ICD therapy, an S-ICD:
S-ICDs are designed to allow self-termination of non-sustained tachyarrhythmias.
Because it leaves the heart untouched and requires few or no upper-body restrictions and few or no athletic restrictions, S-ICD may be a particularly good option for your patients who are 70 and younger, are active, or are hesitant to receive a device.
The Patient Decision Tree will help you make the referral decision.
All trademarks are the property of their respective owner.
Device choice should be based on shared decision-making between HCP and patient.
SC ECG screening is mandatory to evaluate suitability of sensing vectors for the S-ICD.
* Extended Life (EL) TV-ICD models should be prioritized to minimize risk of clinical complications related to device replacement.
** VR-ICD option can be considered if the patient is NOT expected to survive his device.